Search for Clinical Trial Results
Juvenile Myelomonocytic Leukemia - 25 Studies Found
Status | Study |
Not yet recruiting |
Study Name: Busulfan and Cyclophosphamide Instead of Total Boby Irradiation (TBI) and Cyclophosphamide for Hematological Malignancies Hematocrit (HCT) Condition:
|
Active, not recruiting |
Study Name: Treosulfan-based Conditioning in Paediatric Patients With Haematological Malignancies Condition:
|
Recruiting |
Study Name: Natural History and Biology of Long-Term Late Effects Following Hematopoietic Cell Transplant for Childhood Hematologic Malignancies Condition:
|
Completed |
Study Name: Pilot Study of Expanded, Donor Natural Killer Cell Infusions for Refractory Non-B Lineage Hematologic Malignancies and Solid Tumors Condition:
|
Withdrawn |
Study Name: Pacritinib in Combination With Low Dose Decitabine in Intermediate-High Risk Myelofibrosis or Myeloproliferative Neoplasm (MPN)/Myelodysplastic Syndrome (MDS) Condition:
|
Withdrawn |
Study Name: Phase I Dose-Escalation Trial of Clofarabine Followed by Escalating Doses of Fractionated Cyclophosphamide in Children With Relapsed or Refractory Acute Leukemias Condition:
|
Recruiting |
Study Name: CD34+ (Malignant) Stem Cell Selection for Patients Receiving Allogenic Stem Cell Transplant Condition:
|
Terminated |
Study Name: T-Cell Replete Haploidentical Donor Hematopoietic Stem Cell Plus Natural Killer (NK) Cell Transplantation in Patients With Hematologic Malignancies Relapsed or Refractory Despite Previous Allogeneic Transplant Condition:
|
Completed |
Study Name: Stem Cell Transplantation for Patients With Hematologic Malignancies Condition:
|